Agreement combines the capacity and capabilities of OBiO process development scientists with enabling platforms and support from Univercells Technologies.
Will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands.
The plant's automation is integrated from the plant floor through enterprise-level systems and combined with single-use equipment allowing rapid tech transfer.